It's hard to see because so many are blinded by repeated talk of $1000+ per share.
$35 upon FDA approval would represent a 3x gain -- that is significant. The real value won't be recognized until years later when revenue starts coming in and investors can more accurately model future cash flows.
There are a lot of AVXL investors who are married to this stock. I am curious about what price it takes to get them to file for divorce. What may drive the stock price above $35 is if a predominantly retail-owned stock's investors simply refuse to sell shares to funds that were sitting on the sideline until after approval, and Dr. Missling doesn't sell them shares through a private offering. But even under the most extreme supply and demand imbalances, there's no way AVXL is going to hit $1000+ anytime soon. Probably not ever, but as they say let the dreamers continue to dream...
News 
Market Data 
Discover 
